Skip to content
healthcare.dev
Get a free key

HYLENEX Recombinant

NDC 18657-117, Hyaluronidase, injection, solution, from Antares Pharma, Inc..

Product NDC
18657-117
Status
Listed
Labeler
Antares Pharma, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021859
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/18657-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYALURONIDASE (HUMAN RECOMBINANT)150 [USP'U]/mL

Pharmacologic classes

Endoglycosidase [EPC]; Glycoside Hydrolases [CS]

Package NDCNDC-11Package
18657-117-04186570117044 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3023cc56-ed4b-4e87-b3a1-81b20943f658

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=18657-117

  • NADAC price for package 18657011704

    GET /v1/drugs/nadac/18657011704

Use it

Look up 18657-117 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/18657-117 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 18657-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.